Cite
HARVARD Citation
Lilenbaum, R. et al. (2015). A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer. Journal of thoracic oncology. 10 (1), p. . [Online].